Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedUpdated the trial site location name from Tainan City to Tainan (Taiwan, 736) in the Locations section.SummaryDifference0.0%

- Check12 days agoChange DetectedRemoved external health information links (MedlinePlus Genetics, MedlinePlus breast cancer, DailyMed, NIH/NIH.gov, and related resources) from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoChange DetectedAdded external information links to MedlinePlus genetics and breast cancer pages, DailyMed drug information for the therapies listed in the study, Olema publications, and U.S. government sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

- Check48 days agoChange DetectedUpdated version to v3.1.0 and added contact phone number 415-651-7206.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.